On May 30, 2018 the president signed HR 878, granting terminally ill patients the right to try experimental drugs. While there has been significant controversy surrounding this bill it represents an interesting milestone in the public debate...
"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..." Read about how we helped David.
Learn the process we use to test your living cancer cells in the laboratory in order to find the most effective and least toxic regimen for your cancer.
